Biomarkers and method to predict or predict response to treatment with BRAF and MEK inhibitors (BRAFi + MEKi) and for patient follow-up

Categoría
Diagnostics and Personalised Medicine
Tipo de registro
Biotech Sanitaria
Nombre socio
CIBER
Producto / Servicio
Biomarkers and method to predict or predict response to treatment with BRAF and MEK inhibitors (BRAFi + MEKi) and for patient follow-up
Tipo
Biomarkers
Diagnostic
Area terapéutica
Oncología
Propiedades/Indicación
Genetic biomarkers, Cancer
Fase de desarrollo
R&D